Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EssilorLuxottica | Paris | Healthcare | Healthcare Equipment & Supplies | €125.57B | 52.1x | 23.43 | €271.80 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 0.3% Upside | Upgrade to Pro+ | |
| Sanofi | Paris | Healthcare | Pharmaceuticals | €105.57B | 16.8x | 0.14 | €86.49 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 23.9% Upside | Upgrade to Pro+ | |
| Sartorius Stedim | Paris | Healthcare | Healthcare Equipment & Supplies | €17.43B | 77.4x | 2.74 | €179.30 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 30.4% Upside | Upgrade to Pro+ | |
| Biomerieux | Paris | Healthcare | Healthcare Equipment & Supplies | €15B | 34.6x | 1.65 | €126.90 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 0.1% Upside | Upgrade to Pro+ | |
| Eurofins Scientific | Paris | Healthcare | Biotechnology & Medical Research | €13.05B | 33.3x | 1.65 | €67.80 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -6.4% Downside | Upgrade to Pro+ | |
| Ipsen | Paris | Healthcare | Pharmaceuticals | €9.45B | 21.1x | -0.62 | €114.60 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6.2% Upside | Upgrade to Pro+ | |
| Abivax SA | Paris | Healthcare | Biotechnology & Medical Research | €4.44B | -20x | -2.19 | €58.80 | -1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 14.9% Upside | Upgrade to Pro+ | |
| Virbac | Paris | Healthcare | Pharmaceuticals | €2.82B | 19.4x | 0.94 | €337 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 17.2% Upside | Upgrade to Pro+ | |
| Emeis | Paris | Healthcare | Healthcare Providers & Services | €2.28B | -5.4x | 0.04 | €14.13 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -12.2% Downside | Upgrade to Pro+ | |
| Clariane SE | Paris | Healthcare | Healthcare Providers & Services | €1.70B | -28x | -0.28 | €4.70 | -1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 8% Upside | Upgrade to Pro+ | |
| Ramsay Generale De Sante | Paris | Healthcare | Healthcare Providers & Services | €1.10B | -13.8x | 0.02 | €9.96 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Vetoquinol | Paris | Healthcare | Pharmaceuticals | €896.47M | 15.3x | 2.58 | €76 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 15.3% Upside | Upgrade to Pro+ | |
| Valneva | Paris | Healthcare | Biotechnology & Medical Research | €852.87M | -11.7x | 0.17 | €5.04 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 35.1% Upside | Upgrade to Pro+ | |
| Medincell | Paris | Healthcare | Pharmaceuticals | €588.80M | -28.3x | -1.08 | €17.80 | 1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 24.8% Upside | Upgrade to Pro+ | |
| Inventiva | Paris | Healthcare | Biotechnology & Medical Research | €534.17M | -1.2x | 0.11 | €3.80 | 4.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Lumibird SA | Paris | Healthcare | Healthcare Equipment & Supplies | €402.77M | 70.6x | -3.68 | €18.20 | -2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 30.1% Upside | Upgrade to Pro+ | |
| Boiron | Paris | Healthcare | Pharmaceuticals | €368.08M | 32.5x | -0.47 | €21.35 | 1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 18.8% Upside | Upgrade to Pro+ | |
| Nanobiotix | Paris | Healthcare | Biotechnology & Medical Research | €361.32M | -5.3x | 0.16 | €7.53 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 32.5% Upside | Upgrade to Pro+ | |
| LNA Sante SA | Paris | Healthcare | Healthcare Providers & Services | €318M | 14.5x | -2.13 | €31 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 1.6% Upside | Upgrade to Pro+ | |
| Amplitude Surgical SAS | Paris | Healthcare | Healthcare Equipment & Supplies | €297.42M | 273.1x | -2.8 | €6.25 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Euroapi | Paris | Healthcare | Pharmaceuticals | €295.16M | -2.4x | -0.04 | €3.22 | 2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -4.8% Downside | Upgrade to Pro+ | |
| Guerbet | Paris | Healthcare | Healthcare Equipment & Supplies | €283.58M | 17.5x | -0.54 | €22.40 | -2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 22.2% Upside | Upgrade to Pro+ | |
| Eurobio Scientific | Paris | Healthcare | Biotechnology & Medical Research | €255.38M | 65.5x | -6.8 | €25.45 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 17.6% Upside | Upgrade to Pro+ | |
| DBV Technologies | Paris | Healthcare | Pharmaceuticals | €235.24M | -1.8x | 0.1 | €1.71 | -1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -12.6% Downside | Upgrade to Pro+ | |
| Bastide Le Confort | Paris | Healthcare | Healthcare Providers & Services | €203.68M | 22.7x | -0.3 | €27.80 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 47.2% Upside | Upgrade to Pro+ | |
| Genfit | Paris | Healthcare | Biotechnology & Medical Research | €191.54M | 127x | 1.23 | €3.85 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Cellectis | Paris | Healthcare | Biotechnology & Medical Research | €189.49M | -5.3x | -0.08 | €2.65 | 4.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Innate Pharma | Paris | Healthcare | Biotechnology & Medical Research | €182.80M | -3.3x | 0.01 | €2.02 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Adocia | Paris | Healthcare | Biotechnology & Medical Research | €157.57M | -13.7x | -0.27 | €8.63 | -11.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Ose Pharma International SA | Paris | Healthcare | Biotechnology & Medical Research | €153.44M | 3.9x | 0.02 | €6.69 | -3.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Transgene | Paris | Healthcare | Biotechnology & Medical Research | €137.67M | -3.5x | 0.13 | €1.03 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Sensorion SA | Paris | Healthcare | Biotechnology & Medical Research | €105.47M | -3.8x | -0.08 | €0.35 | -4.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Eurofins-Cerep | Paris | Healthcare | Biotechnology & Medical Research | €92.81M | €18,400 | 4.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
| AB Science | Paris | Healthcare | Pharmaceuticals | €92.09M | -9x | -0.32 | €1.32 | -1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Crossject | Paris | Healthcare | Healthcare Equipment & Supplies | €89.88M | -6.1x | 0.36 | €1.72 | 5.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Mediantechn | Paris | Healthcare | Healthcare Equipment & Supplies | €86.28M | -1.9x | 0.37 | €2.53 | -5.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Maat Pharma | Paris | Healthcare | Biotechnology & Medical Research | €86M | -2.7x | 0.11 | €5.90 | 5.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| AbL Diagnostics | Paris | Healthcare | Healthcare Equipment & Supplies | €70.58M | 219x | 0.52 | €4.38 | -2.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 33.6% Upside | Upgrade to Pro+ | |
| Abionyx Pharma SA | Paris | Healthcare | Biotechnology & Medical Research | €66.86M | -14.5x | 1.81 | €1.88 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Klea Holding | Paris | Healthcare | Healthcare Providers & Services | €63.39M | 44.9x | 0.73 | €0.21 | 5.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Affluent Medical | Paris | Healthcare | Healthcare Equipment & Supplies | €59.02M | -2.5x | €1.62 | 5.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
| Impulse Fitness Solutions | Paris | Healthcare | Healthcare Equipment & Supplies | €56.15M | -205.3x | €7 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
| Fermentalg | Paris | Healthcare | Biotechnology & Medical Research | €47.01M | -3x | -0.08 | €0.53 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 42.6% Upside | Upgrade to Pro+ | |
| SMAIO | Paris | Healthcare | Pharmaceuticals | €37.40M | -9.6x | 0.04 | €5.90 | -4.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 12.9% Upside | Upgrade to Pro+ | |
| Novacyt | Paris | Healthcare | Biotechnology & Medical Research | €33.50M | -0.8x | 0.02 | €0.47 | -2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Nicox | Paris | Healthcare | Pharmaceuticals | €33.22M | -0.6x | €0.46 | -5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
| Theraclion SA | Paris | Healthcare | Healthcare Equipment & Supplies | €31.48M | -5.4x | 0.1 | €0.67 | 3.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Diagnostic Medical | Paris | Healthcare | Healthcare Equipment & Supplies | €29.82M | -10.1x | -0.21 | €1.43 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 46.9% Upside | Upgrade to Pro+ | |
| Carmat | Paris | Healthcare | Healthcare Equipment & Supplies | €29.18M | -0.4x | -0.01 | €0.47 | -2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Genoway | Paris | Healthcare | Biotechnology & Medical Research | €28.40M | €3.08 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |